MANGALAM GLOBAL ENTERPRISE
Back to Income Statement
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹3,384 Cr | ₹2,281 Cr | ₹1,839 Cr | ₹1,424 Cr | ₹1,279 Cr |
What is the latest Revenue of MANGALAM GLOBAL ENTERPRISE ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹3,384 Cr |
| Mar2025 | ₹2,281 Cr |
| Mar2024 | ₹1,839 Cr |
| Mar2023 | ₹1,424 Cr |
| Mar2022 | ₹1,279 Cr |
How is Revenue of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,384 Cr | 48.35 | |
| Mar2025 | ₹2,281 Cr | 24.09 | |
| Mar2024 | ₹1,839 Cr | 29.09 | |
| Mar2023 | ₹1,424 Cr | 11.36 | |
| Mar2022 | ₹1,279 Cr | - | |
Compare Revenue of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹579.4 Cr | -2.2% | 10.2% | 20.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,551.9 Cr | 1.4% | 2.1% | -32.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,223.1 Cr | -1.2% | -1.4% | 3.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,527.4 Cr | 2.9% | 5.8% | 37.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹938.6 Cr | 6.4% | 6.5% | NA | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹264.2 Cr | 2.9% | 0.9% | -20.6% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -2.2% |
10.2% |
20.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses